Fig. 8
From: Recent advances of CREKA peptide-based nanoplatforms in biomedical applications
CRE-NP (α-M) pretreatment improved the antitumor effect of CRP-MC (Trip) in pancreatic cancer. A Schematic diagram of different treatment modes in situ tumor model. B IVIS photographs of mice after different treatments. C Tumor growth curves of mice in different treatment groups. D Mice weight change curve. E Survival ratio of mice in different treatment groups. F H&E staining of tumor tissues in different treatment groups [82]